In recognition of his outstanding volunteer contributions in community service to the United States, Bryant Reid was selected for Lifetime Achievement of the President’s Volunteer Service Award. This prestigious recognition is a testament to his steadfast commitment, dedication, and selflessness in serving others throughout his lifetime “His tireless efforts and countless hours of volunteer work, with a primary focus…

Bryant Reid, Founder and Board Chair, of The Reid Foundation for Lupus, Inc. (TRFL) was the featured speaker at the September 12, 2023, meeting of the General Body of the 100 Black Men of Atlanta Inc. Also, speaking at the event was Georgia Tech’s Men’s Head Basketball Coach Damon Stoudamire. The meeting was held in…

Bryant Reid, The Reid Foundation For Lupus Chair, met with Dr. Ignacio Sanz, Emory Division of Rheumatology Director, and Dr. Frances Lee, Emory Department of Medicine Associate Professor at The Lowance Center for Human Immunology. The purpose of the Lowance Center for Human Immunology is to understand the immunological and molecular mechanisms responsible for human…

Congratulations to Roberto Duran on his storied hall-of-fame career. He held the world championships in lightweight, welterweight, light middleweight, and middleweight classes. Ring magazine voted him as the fifth greatest fighter of the last 80 years. He was also voted the best lightweight of the 20th century by the Associated Press. The Reid Foundation for…

Elevating the Male Lupus Voice During Men’s Health Month Read Full Article

New Study Identifies Certain Gut Bacteria as Potential Drivers of Lupus Flares Read Full Article

Read about how the Lupus Foundation of America is uniting communities to raise lupus awareness and support and how you can get involved to help make lupus visible. Read Full Article

Toni Braxton spoke recently about a “traumatic” heart procedure she underwent after she experienced a life-threatening lupus complication. Read Full Article Article Credit: Lupus Foundation of America | lupus.org

New research in machine learning finds four predictive lupus disease profiles. Read Full Article

JW Therapeutics has received approval from the National Medical Products Administration of China to conduct a Phase 1 / 2 clinical trial of its CAR T-cell therapy, relmacabtagene autoleucel (relma-cel), for people with moderate to severe and/or treatment-resistant lupus. CAR T-cells are genetically altered T-cells that play a role in the immune response. Scientists create…